ATRC Earnings & Financial Statements
AtriCure, Inc.
$56.86
-$0.44(-0.77%)
59
Overall
40
Value
66
Tech
71
Quality
Market Cap
$2.91B
Volume
386.60K
52W Range
$25.36 - $61.70
Target Price
$54.89
ATRC earnings and financial statements: AtriCure, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
ATRC Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $534.53M | $465.31M | $399.25M | $330.38M | $274.33M |
| Cost of revenue | $133.75M | $117.78M | $98.88M | $84.44M | $68.47M |
| Operating income | -$9.45M | -$40.01M | -$26.68M | -$42.67M | $55.20M |
| EBITDA | $16.72M | -$18.06M | -$7.62M | -$29.00M | $65.75M |
| Net income | -$11.45M | -$44.70M | -$30.44M | -$46.47M | $50.20M |
| EPS (diluted) | $-0.24 | $-0.95 | $-0.66 | $-1.02 | $1.09 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $654.18M | $609.33M | $613.93M | $585.45M | $615.31M |
| Total liabilities | $162.24M | $148.36M | $147.76M | $128.69M | $131.56M |
| Shareholders’ equity | $491.94M | $460.97M | $466.17M | $456.75M | $483.76M |
| Cash and equivalents | $167.43M | $122.72M | $84.31M | $58.10M | $43.65M |
| Long-term debt | $61.87M | $61.87M | $60.59M | $69.08M | $73.89M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $57.33M | $12.20M | $4.48M | -$22.14M | -$13.78M |
| Capital expenditure | -$9.05M | -$11.43M | -$42.00M | -$16.88M | -$9.75M |
| Free cash flow | $48.28M | $745.0K | -$37.51M | -$39.02M | -$23.53M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ATRC | $56.86 | -0.8% | 386.60K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |